Effectiveness of deep dry needling in active miofascial trigger points in the reduction of non-specific cervical pain

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN22726482

Enrollment

148

Registered

2011-11-08

Start date

2011-06-01

Completion date

Unknown

Last updated

2019-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain Cancer Malignant neoplasm of cervix uteri

Interventions

Patients in the group of "Invasive Physical Therapy" will be treated with deep dry needling in all miofascial active trigger points found in cervical musculature described. They were also be applied a

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Over 18 years old 2. Present a diagnostic of non specific cervical chronic (more than 3 months with pain sintomatology) 3. Neck pain (with non-traumatic antecedents, neurologic infection, discal problems) 4. Present Miofascial active Trigger Points in multifidus, splenius cervicis, levator scapulae and trapezius muscles 5. The pain must be on or over 3 points in Visual Analogue Scale 6. The patients must have signed the informed consent

Exclusion criteria

Exclusion criteria: 1. Patients who present any contraindication for physical therapy treatment as deep dry needling (infection, fever, hypothyroidism, insuperable afraid of needles, injuries on the skin above the needling, metal allergy, cancer, systemic diseases) 2. Psycotic and depresive patients

Design outcomes

Primary

Measure	Time frame
Subjective pain using Visual Analogue Scale (VAS)	—

Secondary

Measure	Time frame
1. Demographic 2. Antropometrics: weight and height 3. Antecedents: evolution time of the problem, previous traumatisms, etc. 4. Assesment of muscles (trapezius, levator scapulae, multifidus, esplenius cervicis) to find presence of Miofascial Active trigger points 5. Pain pressure threshold of active MTrP in mentioned musculature using algometry Foix (Wagner Intruments, USA) in Kg/cm2 6. Cervical articular range of movement (Flexoextension, rotation and lateral flexion (inclination)) using CROM goniometer in degrees 7. Strength (Flexion, extension, rotation and lateral flexion (inclination)) using digital dinamometer Microfet 2 (Hoogan Health Industries, USA) in Newtons 8. If patients have any analgesics (Non steroideal anti-inflamatory drugs)	—

Measure

Time frame

1. Demographic 2. Antropometrics: weight and height 3. Antecedents: evolution time of the problem, previous traumatisms, etc. 4. Assesment of muscles (trapezius, levator scapulae, multifidus, esplenius cervicis) to find presence of Miofascial Active trigger points 5. Pain pressure threshold of active MTrP in mentioned musculature using algometry Foix (Wagner Intruments, USA) in Kg/cm2 6. Cervical articular range of movement (Flexoextension, rotation and lateral flexion (inclination)) using CROM goniometer in degrees 7. Strength (Flexion, extension, rotation and lateral flexion (inclination)) using digital dinamometer Microfet 2 (Hoogan Health Industries, USA) in Newtons 8. If patients have any analgesics (Non steroideal anti-inflamatory drugs)

—

Countries

Spain

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 23, 2026